Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T83875 | ||||
Target Name | Monoamine oxidase type A (MAO-A) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Moclobemide | Drug Info | IC50 = 361380 nM | [31] | |
Tranylcypromine | Drug Info | IC50 = 20000 nM | [7] | ||
(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine | Drug Info | Ki = 19000 nM | [30] | ||
(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one | Drug Info | Ki = 10000 nM | [30] | ||
(+/-)-2-(4'-Butoxyphenyl)thiomorpholine | Drug Info | Ki = 14100 nM | [30] | ||
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one | Drug Info | Ki = 12300 nM | [30] | ||
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine | Drug Info | Ki = 2170 nM | [30] | ||
(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one | Drug Info | Ki = 9280 nM | [30] | ||
(+/-)-2-(4'-Methoxyphenyl)thiomorpholine | Drug Info | Ki = 6390 nM | [30] | ||
(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one | Drug Info | Ki = 8680 nM | [30] | ||
(+/-)-2-(4'-Propoxyphenyl)thiomorpholine | Drug Info | Ki = 3690 nM | [30] | ||
(+/-)-2-Phenylthiomorpholin-5-one | Drug Info | Ki = 9190 nM | [30] | ||
(+/-)-2-Phenylthiomorpholine | Drug Info | Ki = 10600 nM | [30] | ||
(6-Benzyloxy-2-naphthyl)-2-aminopropane | Drug Info | Ki = 3780 nM | [23] | ||
(6-Butoxy-2-naphthyl)-2-aminopropane | Drug Info | Ki = 1530 nM | [23] | ||
(6-Ethoxy-2-naphthyl)-2-aminopropane | Drug Info | Ki = 450 nM | [23] | ||
(6-Methoxy-2-naphthyl)-2-aminopropane | Drug Info | Ki = 180 nM | [23] | ||
(6-methylthio-2-naphthyl)isopropylamine | Drug Info | Ki = 500 nM | [23] | ||
(6-Propoxy-2-naphthyl)-2-aminopropane | Drug Info | Ki = 680 nM | [23] | ||
(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile | Drug Info | IC50 = 200 nM | [26] | ||
(E)-5-(3-Chlorostyryl)isatin | Drug Info | Ki = 5600 nM | [25] | ||
(E)-5-(3-Fluorostyryl)isatin | Drug Info | Ki = 2200 nM | [25] | ||
(E)-5-Styrylisatin | Drug Info | Ki = 780 nM | [25] | ||
(R)-Indan-1-yl-methyl-prop-2-ynyl-amine | Drug Info | IC50 = 70 nM | [3] | ||
(R,S)-N-(R-phenylethyl)-1H-pyrrole-2-carboxamide | Drug Info | Ki = 1220 nM | [12] | ||
(R/R)BEFLOXATONE | Drug Info | Ki = 2.5 nM | [2] | ||
(S)-2-amino-1-(4-butylthiophenyl)-propane | Drug Info | Ki = 392 nM | [13] | ||
(S)-2-amino-1-(4-ethylthiophenyl)-propane | Drug Info | Ki = 54 nM | [13] | ||
(S)-2-amino-1-(4-methylthiophenyl)-propane | Drug Info | Ki = 245 nM | [13] | ||
(S)-2-amino-1-(4-propylthiophenyl)-propane | Drug Info | Ki = 115 nM | [13] | ||
1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole | Drug Info | Ki = 6.5 nM | [6] | ||
1-(1-Naphthyl)-2-aminopropane | Drug Info | Ki = 5630 nM | [23] | ||
1-(2-Naphthyl)-2-aminopropane | Drug Info | Ki = 420 nM | [23] | ||
1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine | Drug Info | IC50 = 2.1 nM | [8] | ||
1-(3-benzyl-6,7-dichloroquinoxalin-2-yl)hydrazine | Drug Info | IC50 = 7.6 nM | [8] | ||
1-(3-benzylquinoxalin-2-yl)hydrazine | Drug Info | IC50 = 8.8 nM | [8] | ||
1-(4-(benzyloxy)phenyl)propan-2-amine | Drug Info | Ki = 3420 nM | [23] | ||
1-(4-butoxyphenyl)propan-2-amine | Drug Info | Ki = 320 nM | [23] | ||
1-(4-ethoxyphenyl)propan-2-amine | Drug Info | Ki = 220 nM | [23] | ||
1-(4-propoxyphenyl)propan-2-amine | Drug Info | Ki = 130 nM | [23] | ||
2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole | Drug Info | Ki = 4.7 nM | [5] | ||
2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole | Drug Info | IC50 = 14851 nM | |||
2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole | Drug Info | IC50 = 7883 nM | |||
2-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazole | Drug Info | Ki = 13570 nM | [21] | ||
2-(3-benzylquinoxalin-2-ylamino)ethanol | Drug Info | IC50 = 3.7 nM | [8] | ||
2-(4,5-dihydro-1H-imidazol-2-yl)quinoline | Drug Info | IC50 = 12700 nM | [21] | ||
2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazole | Drug Info | Ki = 15750 nM | [21] | ||
2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole | Drug Info | Ki = 13890 nM | [21] | ||
2-Amino-1-(4-methylthiophenyl)propane | Drug Info | Ki = 250 nM | [23] | ||
2-BFi | Drug Info | Ki = 1.7 nM | [1] | ||
2-Bromo-N-(2-morpholinoethyl)nicotinamide | Drug Info | IC50 = 8500 nM | [29] | ||
2-Chloro-N-(2-morpholinoethyl)nicotinamide | Drug Info | IC50 = 2600 nM | [29] | ||
2-Chloro-N-(3-morpholinopropyl)nicotinamide | Drug Info | IC50 = 9400 nM | [29] | ||
2-Furan-2-yl-4,5-dihydro-1H-imidazole | Drug Info | Ki = 2340 nM | [4] | ||
2-oxo-N-m-tolyl-2H-chromene-3-carboxamide | Drug Info | IC50 = 14500 nM | [24] | ||
2-oxo-N-p-tolyl-2H-chromene-3-carboxamide | Drug Info | IC50 = 19450 nM | [24] | ||
2-oxo-N-phenyl-2H-chromene-3-carboxamide | Drug Info | IC50 = 13120 nM | [24] | ||
2-Phenethyl-4,5-dihydro-1H-imidazole | Drug Info | Ki = 5 nM | [4] | ||
2-Phenoxymethyl-4,5-dihydro-1H-imidazole | Drug Info | Ki = 5 nM | [4] | ||
2-phenyl-5H-indeno[1,2-d]pyrimidine | Drug Info | IC50 = 18000 nM | [15] | ||
2-phenyl-9H-indeno[2,1-d]pyrimidine | Drug Info | IC50 = 16700 nM | [15] | ||
2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide | Drug Info | IC50 = 8000 nM | [26] | ||
3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin | Drug Info | IC50 = 2380 nM | [18] | ||
3,4-Benzo-7-acetonyloxy-8-methoxycoumarin | Drug Info | IC50 = 11930 nM | [18] | ||
3,4-Benzo-7-acetonyloxy-8-methylcoumarin | Drug Info | IC50 = 2560 nM | [18] | ||
3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide | Drug Info | Ki = 2580 nM | [32] | ||
3-aminoacetamido-4'-methylfuro[3,2-g]coumarin | Drug Info | IC50 = 12350 nM | [9] | ||
3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine | Drug Info | IC50 = 1.3 nM | [8] | ||
3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide | Drug Info | Ki = 8180 nM | [32] | ||
3-methyl-2(1H)-thioxo-4(3H)-quinazolinone | Drug Info | IC50 = 3420 nM | [22] | ||
4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin | Drug Info | IC50 = 400 nM | [18] | ||
4,9-Dihydro-3H-beta-carboline | Drug Info | Ki = 7.3 nM | [6] | ||
4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid | Drug Info | IC50 = 9970 nM | [24] | ||
4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one | Drug Info | IC50 = 4400 nM | [26] | ||
4-Chloro-N-(2-morpholinoethyl)nicotinamide | Drug Info | IC50 = 750 nM | [29] | ||
4-Chloro-N-(3-morpholinopropyl)nicotinamide | Drug Info | IC50 = 7500 nM | [29] | ||
4-methyl-2H-benzofuro[3,2-g]chromen-2-one | Drug Info | IC50 = 7240 nM | [9] | ||
4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one | Drug Info | IC50 = 40.5 nM | [18] | ||
5,6-Dichloro-N-(2-morpholinoethyl)nicotinamide | Drug Info | IC50 = 84 nM | [29] | ||
5,6-Dichloro-N-(3-morpholinopropyl)nicotinamide | Drug Info | IC50 = 100 nM | [29] | ||
5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one | Drug Info | Ki = 200 nM | [2] | ||
5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 5.4 nM | [5] | ||
5-Bromo-4,9-dihydro-3H-beta-carboline | Drug Info | Ki = 86 nM | [5] | ||
5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 300 nM | [5] | ||
5-Methoxy-4,9-dihydro-3H-beta-carboline | Drug Info | Ki = 84 nM | [5] | ||
5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one | Drug Info | Ki = 4.9 nM | [2] | ||
6,11-dihydro-5H-benzo[a]carbazole | Drug Info | IC50 = 12000 nM | [15] | ||
6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one | Drug Info | IC50 = 12200 nM | [18] | ||
6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 2785 nM | [5] | ||
6-Bromo-4,9-dihydro-3H-beta-carboline | Drug Info | Ki = 790 nM | [5] | ||
6-Chloro-N-(2-morpholinoethyl)nicotinamide | Drug Info | IC50 = 180 nM | [29] | ||
6-Chloro-N-(3-morpholinopropyl)nicotinamide | Drug Info | IC50 = 380 nM | [29] | ||
6-Fluoro-N-(2-morpholinoethyl)nicotinamide | Drug Info | IC50 = 15000 nM | [29] | ||
6-Hydroxy-N-(2-morpholinoethyl)nicotinamide | Drug Info | IC50 = 430 nM | [29] | ||
6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 1640 nM | [6] | ||
6-Methoxy-4,9-dihydro-3H-beta-carboline | Drug Info | Ki = 480 nM | [6] | ||
7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin | Drug Info | Ki = 11000 nM | [16] | ||
7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin | Drug Info | IC50 = 3.78 nM | [18] | ||
7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin | Drug Info | IC50 = 235 nM | [18] | ||
7-acetonyloxy-3-acetylamino-8-methoxycoumarin | Drug Info | IC50 = 6430 nM | [9] | ||
7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 1290 nM | [5] | ||
7-Bromo-4,9-dihydro-3H-beta-carboline | Drug Info | Ki = 400 nM | [5] | ||
7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 12 nM | [4] | ||
7-Methoxy-9H-beta-carboline | Drug Info | Ki = 87 nM | [5] | ||
8-(3-Bromobenzyloxy)caffeine | Drug Info | Ki = 23 nM | [28] | ||
8-(3-Chlorobenzyloxy)caffeine | Drug Info | Ki = 36 nM | [28] | ||
8-(3-Fluorobenzyloxy)caffeine | Drug Info | Ki = 180 nM | [28] | ||
8-(3-Methoxybenzyloxy)caffeine | Drug Info | Ki = 340 nM | [28] | ||
8-(3-Methylbenzyloxy)caffeine | Drug Info | Ki = 180 nM | [28] | ||
8-Benzyloxycaffeine | Drug Info | Ki = 590 nM | [28] | ||
8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 3.6 nM | [5] | ||
8-Bromo-4,9-dihydro-3H-beta-carboline | Drug Info | Ki = 17 nM | [5] | ||
8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 270 nM | [5] | ||
8-Methoxy-4,9-dihydro-3H-beta-carboline | Drug Info | Ki = 160 nM | [5] | ||
8-[(3-Trifluoromethyl)benzyloxy]caffeine | Drug Info | Ki = 51 nM | [28] | ||
9-(3-aminopropoxy)-7H-furo[3,2-g]chromen-7-one | Drug Info | IC50 = 2510 nM | [9] | ||
9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline | Drug Info | Ki = 5.4 nM | [5] | ||
Beta-methoxyamphetamine | Drug Info | Ki = 250 nM | [23] | ||
C-(1H-Indol-3-yl)-methylamine | Drug Info | Ki = 3440 nM | [5] | ||
CGS-19281A | Drug Info | Ki = 18 nM | [6] | ||
Cis-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine | Drug Info | IC50 = 18000 nM | [17] | ||
Cis-2-phenylcyclopropylamine | Drug Info | IC50 = 11000 nM | [17] | ||
Ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate | Drug Info | IC50 = 15980 nM | [24] | ||
Harmine | Drug Info | Ki = 5 nM | [27] | ||
HYDRAZINECARBOXAMIDE | Drug Info | IC50 = 6700 nM | [7] | ||
IPRONIAZIDE | Drug Info | IC50 = 5000 nM | [29] | ||
MOFEGILINE | Drug Info | Ki = 1100 nM | [20] | ||
N'-(2-phenylallyl)hydrazine hydrochloride | Drug Info | IC50 = 1300 nM | [10] | ||
N-((1H-indol-2-yl)methyl)(phenyl)methanamine | Drug Info | Ki = 2100 nM | [19] | ||
N-((1H-indol-2-yl)methyl)-2-phenylethanamine | Drug Info | Ki = 1600 nM | [19] | ||
N-(1-Methyl-1H-indol-2-ylmethyl)-N-phenylamine | Drug Info | Ki = 10 nM | [19] | ||
N-(1H-Indol-2-ylmethyl)-N-(4-phenylbutyl)amine | Drug Info | Ki = 10000 nM | [19] | ||
N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine | Drug Info | Ki = 10 nM | [19] | ||
N-(1H-Indol-2-ylmethyl)-N-phenylamine | Drug Info | Ki = 10000 nM | [19] | ||
N-(2-benzyl),N-(1-methylpyrrol-2-ylmethyl)amine | Drug Info | Ki = 24 nM | [12] | ||
N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide | Drug Info | Ki = 18290 nM | [32] | ||
N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine | Drug Info | Ki = 20 nM | [12] | ||
N-(2-Phenylethyl)-1H-indole-2-carboxamide | Drug Info | Ki = 170 nM | [19] | ||
N-(3-Phenylpropyl)-1H-indole-2-carboxamide | Drug Info | Ki = 5 nM | [19] | ||
N-(3-phenylpropyl)-1H-pyrrole-2-carboxamide | Drug Info | Ki = 700 nM | [12] | ||
N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide | Drug Info | IC50 = 15670 nM | [24] | ||
N-(4-Phenylbutyl)-1H-indole-2-carboxamide | Drug Info | Ki = 2200 nM | [19] | ||
N-(4-phenylbutyl)-1H-pyrrole-2-carboxamide | Drug Info | Ki = 55 nM | [12] | ||
N-(benzyl),N-(pyrrol-2-ylmethyl)amine | Drug Info | Ki = 350 nM | [12] | ||
N-(propargyl),N-(pyrrol-2-ylmethyl)amine | Drug Info | Ki = 300 nM | [12] | ||
N-2-phenylethyl-1H-pyrrole-2-carboxamide | Drug Info | Ki = 420 nM | [12] | ||
N-Benzyl,N-methyl-1H-indole-2-carboxamide | Drug Info | Ki = 70 nM | [19] | ||
N-benzyl,N-methyl-1H-pyrrole-2-carboxamide | Drug Info | Ki = 600 nM | [12] | ||
N-Benzyl-(6-butoxy-2-naphthyl)-2-aminopropane | Drug Info | Ki = 14500 nM | [23] | ||
N-Benzyl-(6-methoxy-2-naphthyl)-2-aminopropane | Drug Info | Ki = 6930 nM | [23] | ||
N-Benzyl-1H-indole-2-carboxamide | Drug Info | Ki = 30 nM | [19] | ||
N-benzyl-1H-pyrrole-2-carboxamide | Drug Info | Ki = 250 nM | [12] | ||
N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine | Drug Info | Ki = 60 nM | [19] | ||
N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine | Drug Info | Ki = 3500 nM | [12] | ||
N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine | Drug Info | Ki = 5.4 nM | [12] | ||
N-Methyl,N-phenyl-1H-indole-2-carboxamide | Drug Info | Ki = 3.5 nM | [19] | ||
N-methyl-N-(prop-2-ynyl)-1H-pyrrole-2-carboxamide | Drug Info | Ki = 75 nM | [12] | ||
N-Phenyl-1-methyl-1H-indole-2-carboxamide | Drug Info | Ki = 10000 nM | [19] | ||
N-Phenyl-1H-indole-2-carboxamide | Drug Info | Ki = 130 nM | [19] | ||
N-phenyl-1H-pyrrole-2-carboxamide | Drug Info | Ki = 400 nM | [12] | ||
N-propargyl-1H-pyrrole-2-carboxamide | Drug Info | Ki = 230 nM | [12] | ||
N2-[4-(benzyloxy)benzyl]glycinamide | Drug Info | IC50 = 8500 nM | [14] | ||
N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide | Drug Info | IC50 = 13600 nM | [14] | ||
N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide | Drug Info | IC50 = 12400 nM | [14] | ||
Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate | Drug Info | Ki = 12840 nM | [21] | ||
PIPERINE | Drug Info | Ki = 19000 nM | [27] | ||
PNU-22394 | Drug Info | Ki = 1030 nM | [5] | ||
TOLOXATONE | Drug Info | Ki = 1800 nM | [11] | ||
TRACIZOLINE | Drug Info | Ki = 2 nM | [4] | ||
Trans-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine | Drug Info | IC50 = 10000 nM | [17] | ||
Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine | Drug Info | IC50 = 1600 nM | [17] | ||
Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine | Drug Info | IC50 = 3600 nM | [17] | ||
Trans-2-fluoro-2-p-tolylcyclopropanamine | Drug Info | IC50 = 13000 nM | [17] | ||
Trans-2-fluoro-2-phenylcyclopropylamin | Drug Info | IC50 = 12000 nM | [17] | ||
TRYPTAMINE | Drug Info | Ki = 5400 nM | [5] | ||
TRYPTOLINE | Drug Info | Ki = 9.4 nM | [4] | ||
References | |||||
REF 1 | Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. Bioorg Med Chem Lett. 2000 Mar 20;10(6):605-7. | ||||
REF 2 | 3-(1H-Pyrrol-1-yl)-2-oxazolidinones as reversible, highly potent, and selective inhibitors of monoamine oxidase type A. J Med Chem. 2002 Mar 14;45(6):1180-3. | ||||
REF 3 | Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. J Med Chem. 2002 Nov 21;45(24):5260-79. | ||||
REF 4 | Binding of an imidazopyridoindole at imidazoline I2 receptors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):527-9. | ||||
REF 5 | Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation. Bioorg Med Chem Lett. 2004 Feb 23;14(4):999-1002. | ||||
REF 6 | Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands. Bioorg Med Chem Lett. 2004 Feb 23;14(4):1003-5. | ||||
REF 7 | Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxi... J Med Chem. 2004 Nov 18;47(24):5860-71. | ||||
REF 8 | Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1753-6. | ||||
REF 9 | A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. J Med Chem. 2006 Feb 9;49(3):1149-56. | ||||
REF 10 | Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. J Med Chem. 2006 Apr 6;49(7):2166-73. | ||||
REF 11 | Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and ... J Nat Prod. 2006 Jun;69(6):945-9. | ||||
REF 12 | New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. J Med Chem. 2007 Mar 8;50(5):922-31. | ||||
REF 13 | Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies. Bioorg Med Chem. 2007 Aug 1;15(15):5198-206. | ||||
REF 14 | Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16. | ||||
REF 15 | Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives. J Med Chem. 2007 Nov 1;50(22):5364-71. | ||||
REF 16 | Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem. 2007 Nov 15;50(23):5848-52. | ||||
REF 17 | Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases... Bioorg Med Chem. 2008 Aug 1;16(15):7148-66. | ||||
REF 18 | Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008 Nov 13;51(21):6740-51. | ||||
REF 19 | Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B. Bioorg Med Chem. 2008 Nov 15;16(22):9729-40. | ||||
REF 20 | Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B. J Med Chem. 2008 Dec 25;51(24):8019-26. | ||||
REF 21 | Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors. Bioorg Med Chem Lett. 2009 Jan 15;19(2):546-9. | ||||
REF 22 | New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A ... Bioorg Med Chem. 2009 Jan 15;17(2):675-89. | ||||
REF 23 | Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors. Bioorg Med Chem. 2009 Mar 15;17(6):2452-60. | ||||
REF 24 | Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem. 2009 Apr 9;52(7):1935-42. | ||||
REF 25 | Inhibition of monoamine oxidase by (E)-styrylisatin analogues. Bioorg Med Chem Lett. 2009 May 1;19(9):2509-13. | ||||
REF 26 | Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)ox... J Med Chem. 2009 Nov 12;52(21):6685-706. | ||||
REF 27 | Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Bioorg Med Chem Lett. 2010 Jan 15;20(2):537-40. | ||||
REF 28 | Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues. Bioorg Med Chem. 2010 Feb;18(3):1018-28. | ||||
REF 29 | Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1659-64. | ||||
REF 30 | 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1388-95. | ||||
REF 31 | Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B. Bioorg Med Chem Lett. 2010 May 1;20(9):2709-12. | ||||
REF 32 | Inhibition of monoamine oxidase by indole and benzofuran derivatives. Eur J Med Chem. 2010 Oct;45(10):4458-66. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.